Comment on Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'Comments−anotherhue1moTo be fair buying securities or derivatives ahead of a pharma results announcement is pretty common already.Not to excuse these guys for all their other awfulness of course.
Comments
To be fair buying securities or derivatives ahead of a pharma results announcement is pretty common already.
Not to excuse these guys for all their other awfulness of course.